The global biopharmaceutical CMO & CRO market was valued at USD XX Bn in 2019 and is expected to reach USD XX Bn by2027, with a CAGR of XX% during the forecast period.Biopharmaceuticals are medical drugs produced using biotechnology, that is, therapeutic products created through the genetic manipulation of living cells or organisms. Contract research organizations (CROs) are...

In the pharmaceutical industry, stakeholders are known to adopt a variety partnership models. Such initiatives not only allow the companies to expand their respective product / therapy, but also to gain additional capabilities in emerging technologies. In the domain of TIL-based therapies, eleven different types of partnership deals were found to be inked between different stakeholders. These...

In the pharmaceutical industry, stakeholders are known to adopt a variety partnership models. Such initiatives not only allow the companies to expand their respective product / therapy, but also to gain additional capabilities in emerging technologies. In the domain of TIL-based therapies, eleven different types of partnership deals were found to be inked between different stakeholders. These...

In the pharmaceutical industry, stakeholders are known to adopt a variety partnership models. Such initiatives not only allow the companies to expand their respective product / therapy, but also to gain additional capabilities in emerging technologies. In the domain of TIL-based therapies, eleven different types of partnership deals were found to be inked between different stakeholders. These...

Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.   Given the...